Hi there,
Together with BioInformant, I am excited to share the details of the 5th iPSC Drug Development Summit (October 1-2, 2025) - the industry’s longest-standing and most trusted forum dedicated to advancing iPSC-derived therapies from bench to bedside. Given the scope of this event, I wanted to highlight a few key details from this year's meeting, as it would be great to have members of your company in the room.
View the 2025 Agenda
| What Is The Summit About? |
Returning to Boston, MA, this two-track meeting focuses on the niche challenges that only iPSC-based developers face, such as fine-tuning culture conditions for differentiation, preventing genomic instability, and analyzing end cell types.
View the full agenda to find out more. |
| Who Will You Meet? |
You'll hear from over 30 expert speakers ranging from:
- Big pharma such as Novo Nordisk and Vertex Pharmaceuticals
- Industry-leading biotechs such as Aspen Neuroscience, Century Therapeutics, and BlueRock Therapeutics
- Novel start-ups with disruptive technology, such as Theseus Therapies, Orizuru Therapeutics, and Thymmune Therapeutics
Our speaker faculty will share their insights across various ontologies, and you will have the opportunity to ask any burning questions in our open discussion forum. |
| Why Attend? |
Whether you're working in oncology, neurology, cardiology, or regenerative medicine, this is where the global iPSC community gathers to benchmark progress, share insights, and solve the toughest challenges from genetic engineering and cell line selection to GMP manufacturing and regulatory navigation. |
If you are invested in the success of iPSC-based drug development, this is where you need to be!
We want to ensure that as many voices as possible can participate in this year's meeting; therefore, the summit is free to attend for biopharma and academics. You can secure your complimentary pass here: www.ipsc-therapies-summit/register.com
Best wishes,
Selin
Selin Ibrahimov
Senior Program Director - 5th iPSC Drug Development Summit
Hanson Wade
.png)